Cg Oncology Inc (CGON) ticks all the boxes for top investors with its surprise performance of -9.59% last month.

Shaun Noe

On Tuesday, Cg Oncology Inc (NASDAQ: CGON) opened lower -3.43% from the last session, before settling in for the closing price of $40.22. Price fluctuations for CGON have ranged from $14.80 to $45.56 over the past 52 weeks.

Company’s average yearly earnings per share was noted -50.32% at the time writing. With a float of $45.56 million, this company’s outstanding shares have now reached $76.23 million.

Cg Oncology Inc (CGON) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cg Oncology Inc is 40.24%, while institutional ownership is 79.41%. The most recent insider transaction that took place on Oct 13 ’25, was worth 43,250. In this transaction Director of this company sold 1,000 shares at a rate of $43.25, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director sold 5,903 for $43.99, making the entire transaction worth $259,673. This insider now owns 0 shares in total.

Cg Oncology Inc (CGON) Latest Financial update

If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.3 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.34) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -50.32% per share during the next fiscal year.

Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators

Check out the current performance indicators for Cg Oncology Inc (CGON). In the past quarter, the stock posted a quick ratio of 22.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5384.47.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -2.42 in one year’s time.

Technical Analysis of Cg Oncology Inc (CGON)

The latest stats from [Cg Oncology Inc, CGON] show that its last 5-days average volume of 0.96 million was inferior to 0.99 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.48%.

During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 69.33%, which indicates a significant increase from 32.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.11 in the past 14 days, which was higher than the 1.67 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $39.03, while its 200-day Moving Average is $29.05. Now, the first resistance to watch is $40.94. This is followed by the second major resistance level at $43.05. The third major resistance level sits at $45.62. If the price goes on to break the first support level at $36.27, it is likely to go to the next support level at $33.70. The third support level lies at $31.59 if the price breaches the second support level.

Cg Oncology Inc (NASDAQ: CGON) Key Stats

There are currently 76,248K shares outstanding in the company with a market cap of 2.96 billion. Presently, the company’s annual sales total 1,140 K according to its annual income of -88,040 K. Last quarter, the company’s sales amounted to 50 K and its income totaled -34,450 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.